FILE 05 / CONTACT
Bring a critique, a dataset, or the expertise the project lacks.
Norysr is looking for technical and clinical review before it looks for attention. Read the contract summary and the side study, point to the weak assumption, and make the next experiment harder to fool.
A dedicated public review channel has not yet been published. Direct email is not posted here because of automated scraping.
01 / REVIEW CHANNEL
The review route is still a release decision.
Current status
Not yet published
The team must choose a monitored issue tracker or team-reviewed email route before public outreach.
Useful subject line
Norysr review: [clinical / embedded / data / regulatory]
Include the page, requirement, parameter or citation you want to discuss.
02 / USEFUL REVIEW
The project needs specific criticism.
Clinical workflow
Is the provisional cohort (ages 6 to 17, unilateral spastic CP, GMFCS I to II, supervised level walking) the right first population, and which fitting assumptions fail in real sessions?
Embedded system
Can a 1,603-parameter causal model, its preprocessing and the deterministic supervisor meet the provisional 10 ms update, 30 ms decision and 50 ms freshness targets on candidate microcontrollers?
Data access
Is there a licensable gait dataset with pediatric CP participants, a distal-shank inertial sensor and an independent synchronized gait-event reference such as pressure insoles or motion capture?
Signal processing
Are the seven synthetic artifact families of the EEG side study realistic enough, and how should band-power fidelity be weighed against waveform error when a cleaning step precedes a comparison across people?
Safety and regulation
Which failure modes, standards or assumptions are missing from the v0.1 contract and its open-decision list?
03 / BOUNDARY
What this contact page does not offer.
- Norysr is not a clinical service and cannot provide medical advice.
- No device is available for sale, fitting or participant use.
- No hospital, university or manufacturer has endorsed the project.
- No investment round or commercial partnership is being represented here.